< Back to search
Filter
1

FES BPET-DBT in Newly Diagnosed Breast Cancer

for
Breast Cancer
Location: Philadelphia PA
Sponsor: Abramson Cancer Center at Penn Medicine

Sex: Female

Age: 18+

Code: NCT05659797

Early_phase1, Recruiting

Positron Emission Mammography and Liquid Biopsy in Women With High-risk Breast Screenings

for
Breast Cancer
Location: Toronto
Sponsor: University Health Network, Toronto

Sex: Female

Age: 18+

Code: NCT06268405

Recruiting

Neoadjuvant INBRX-106 in Combination With Pembrolizumab for Stage II/III TNBC Patients

for
Triple Negative Breast Cancer
Location: Portland OR, Los Angeles CA
Sponsor: Providence Health & Services

Sex: All

Age: 18+

Code: NCT06353997

Phase2, Recruiting

Alpelisib/iNOS Inhibitor/Nab-paclitaxel in Patients With HER2 Negative Metaplastic Breast Cancer (MpBC)

for
HER2-negative Breast Cancer, Metastatic Breast Cancer,
Location: Bethesda MD, Houston TX
Sponsor: The Methodist Hospital Research Institute

Sex: All

Age: 18+

Code: NCT05660083

Phase2, Recruiting

Sacituzumab Govitecan +/- Pembrolizumab in Metastatic TNBC

for
Breast Cancer, Triple Negative Breast Cancer, PD-L1 Negative
Location: Brewer ME, South Weymouth MA, Boston MA, Foxborough MA,
Sponsor: Dana-Farber Cancer Institute

Sex: All

Age: 18+

Code: NCT04468061

Phase2, Recruiting

Interested in new breast cancer trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

This is a Phase 1 Trial of ZM008, an Anti-LLT1 Antibody, Used as Single Agent Followed by Combination Treatment With Toripalimab in Patients With Advanced Solid Tumors

for
Non Small Cell Lung Cancer,
Location: Boston MA, Austin, TX 78758 TX, San Antonio TX
Sponsor: Zumutor Biologics Inc.

Sex: All

Age: 18+

Code: NCT06451497

Phase1, Recruiting

HER2-positive Breast Cancer Registry

for
HER2 + Breast Cancer
Location: Westwood KS
Sponsor: Priyanka Sharma

Sex: All

Age: 18+

Code: NCT06603597

Recruiting

Surveillance MRI Registry for Patients Who Had Breast Cancer With Dense Breast Tissue

for
Breast Cancer
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: Female

Age: 18+

Code: NCT06127797

Recruiting

A Study to Evaluate Safety, Tolerability and Preliminary Activity of AGX101 in Participants With Advanced Solid Tumors

for
Cancer, Advanced Cancer, Locally Advanced Carcinoma,
Location: Fairfax VA, Sarasota FL, Nashville TN, St Louis MO,
Sponsor: Angiex, Inc.

Sex: All

Age: 18+

Code: NCT06440005

Phase1, Recruiting

The Study of Biodistribution and Dosimetry of 99mTc-Glycopeptide(99mTc-GP) in Patients With Breast Cancer

for
Breast Cancer
Location: Houston TX
Sponsor: SeeCure LLC

Sex: All

Age: 18+

Code: NCT01159405

Phase1, Recruiting

Investigating the Effects of Atezolizumab in People Whose Tumour DNA or RNA Indicates Possible Sensitivity

for
Breast Cancer, Lung Cancer, Gastrointestinal Cancer,
Location: Vancouver
Sponsor: British Columbia Cancer Agency

Sex: All

Age: 18+

Code: NCT04273061

Phase2, Recruiting

An Investigational Scan (64Cu-DOTA-Trastuzumab PET/MRI) in Imaging Patients With HER2+ Breast Cancer With Brain Metastasis

for
Anatomic Stage IV Breast Cancer AJCC v8,
Location: Duarte CA
Sponsor: City of Hope Medical Center

Sex: All

Age: 18+

Code: NCT05376878

Recruiting

Metformin for the Treatment of Insulin Resistance in Women With Stage I-III Breast Cancer Completing Chemotherapy

for
Anatomic Stage I Breast Cancer AJCC v8,
Location: Duarte CA
Sponsor: City of Hope Medical Center

Sex: Female

Age: 18+

Code: NCT06763328

Phase3, Recruiting

Empowering Vulnerable and Resilient Latinas to Obtain Breast Cancer Care

for
Breast Cancer
Location: Chicago IL
Sponsor: University of Illinois at Chicago

Sex: Female

Age: 30+

Code: NCT05483283

Recruiting

RAD 1802: Pilot Trial of Five Fraction Stereotactic Body Radiotherapy for Early Stage Breast Cancer Patients Eligible for Post-Operative Accelerated Partial Breast Irradiation (APBI)

for
Breast Cancer
Location: Birmingham AL
Sponsor: University of Alabama at Birmingham

Sex: All

Age: 18 - 70+

Code: NCT03643861

Recruiting

DATO-BASE: DATOpotamab-deruxtecan for Breast Cancer Brain metAstaSEs

for
Breast Cancer, Breast Cancer Female,
Location: Boston MA, Durham NC, Miami FL
Sponsor: Nancy Lin, MD

Sex: All

Age: 18+

Code: NCT06176261

Phase2, Recruiting

VS-6766+Abema+Fulv in Met HR+/HER- BC

for
Breast Cancer, Hormone Receptor-positive Breast Cancer,
Location: Boston MA
Sponsor: Adrienne G. Waks

Sex: All

Age: 18+

Code: NCT05608252

Phase1, Phase2, Recruiting

Same-Day Discharge After Nipple-sparing Mastectomy or Skin-sparing Mastectomy With Breast Reconstruction

for
Breast Cancer, Mastectomy; Lymphedema, Same Day Surgery,
Location: Baltimore MD, Washington DC
Sponsor: Georgetown University

Sex: Female

Age: 18+

Code: NCT04596683

Recruiting

BGB-43395 Alone or as Part of Combination Therapies in Participants With Breast Cancer and Other Advanced Solid Tumors

for
Advanced Solid Tumor, Advanced Breast Cancer,
Location: Durham NC, Columbus OH, Nashville TN, Denver CO,
Sponsor: BeOne Medicines

Sex: All

Age: 18+

Code: NCT06120283

Phase1, Recruiting

Remotely Delivered, Community-Aligned Weight Loss Interventions Among Breast Cancer Survivors, ¡Vida! Trial

for
Anatomic Stage I Breast Cancer AJCC v8,
Location: Seattle WA
Sponsor: Fred Hutchinson Cancer Center

Sex: Female

Age: 18+

Code: NCT05930483

Recruiting